LPL Financial’s Anixa Biosciences ANIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Buy
111,535
+30,559
+38% +$85K ﹤0.01% 5420
2026
Q1
$209K Sell
80,976
-8,629
-10% -$25.6K ﹤0.01% 5465
2025
Q4
$280K Buy
89,605
+2,600
+3% +$10.6K ﹤0.01% 5197
2025
Q3
$287K Buy
87,005
+11,818
+16% +$37.4K ﹤0.01% 5078
2025
Q2
$248K Buy
75,187
+18,250
+32% +$52.1K ﹤0.01% 4919
2025
Q1
$163K Buy
56,937
+14,000
+33% +$40K ﹤0.01% 4922
2024
Q4
$99.6K Buy
42,937
+11,633
+37% +$36.1K ﹤0.01% 4999
2024
Q3
$98.6K Buy
31,304
+12
+0% +$37 ﹤0.01% 4892
2024
Q2
$69.2K Buy
31,292
+4,600
+17% +$13K ﹤0.01% 4800
2024
Q1
$83.3K Sell
26,692
-1,450
-5% -$5.78K ﹤0.01% 4706
2023
Q4
$109K Buy
28,142
+4
+0% +$13 ﹤0.01% 4536
2023
Q3
$92K Buy
28,138
+5,250
+23% +$18.4K ﹤0.01% 4440
2023
Q2
$73.2K Sell
22,888
-222
-1% -$855 ﹤0.01% 4383
2023
Q1
$99.4K Buy
23,110
+1,000
+5% +$4.38K ﹤0.01% 4206
2022
Q4
$94K Buy
22,110
+222
+1% +$1.07K ﹤0.01% 4185
2022
Q3
$108K Hold
21,888
﹤0.01% 4089
2022
Q2
$67K Buy
+21,888
New +$69K ﹤0.01% 4194

Other funds holding ANIX

LPL Financial's ANIX Position: Q2 2026 in Review

LPL Financial increased its Anixa Biosciences (ANIX) stake by 38% in Q2 2026, buying an estimated $85K and bringing the position to 111,535 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #5420.

LPL Financial first reported a position in ANIX in Q2 2022 and has held it in 17 quarters since. 26 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • LPL Financial held 111,535 shares of Anixa Biosciences worth $312K as of Q2 2026.
  • LPL Financial bought 30,559 Anixa Biosciences shares in Q2 2026, an estimated $85K.
  • Anixa Biosciences made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5420 holding.
  • LPL Financial first reported a position in Anixa Biosciences in Q2 2022 and has held it in 17 quarters since.
  • 26 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.